Use of a Novel Parent-Report Measure to Improve Childhood Vaccine Uptake: The Screening for Hesitancy to Optimize Talk (SHOT) Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 562
- 主要终点
- Child's Mean Percent Days Under-immunized
研究概览
简要总结
The overall goal of this project is to determine whether integrating a novel parent-report measure of vaccine hesitancy into pediatric primary care is effective in improving acceptance of childhood vaccines among vaccine-hesitant parents.
详细描述
The primary goal of this project is to evaluate the effectiveness of an innovative intervention designed to address these barriers-the Screening for Hesitancy to Optimize Talk (SHOT) intervention-in improving provider-parent vaccine discussions and increasing vaccine acceptance. The SHOT intervention involves administering a validated parent-report measure to parents and communicating their score and item-specific responses to their child's provider before their child's 2 and 6 month health supervision visits. The survey contains 15 questions regarding Health Belief Model concepts that influence parent vaccination behavior and has been shown to predict under-immunization.
Our specific aims are to (1) evaluate the impact of the SHOT intervention on a child's immunization status using a matched-pair, cluster randomized controlled trial design; (2) assess how parents' ratings of their vaccine discussions with their child's provider change as a function of the SHOT intervention; and (3) compare pre- and post-study perceptions of barriers to quality vaccine discussions with parents between providers in the SHOT and control arm.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- Triple (Participant, Care Provider, Investigator)
入排标准
- 年龄范围
- 1 Day 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Parents: Parents must be English speaking, ≥18 years old, have a newborn singleton infant ≤2 months, born at ≥35 weeks gestation who is receiving pediatric care at an enrolled Kaiser Permanente or Allegro Pediatrics clinic, and be vaccine hesitant (defined as positive screening score on eligibility survey).
- •Newborns: Newborns 0 - 2 months old whose parents enroll in the study will be invited to participate.
- •Providers: All pediatric and family practice providers at Kaiser Permanente and Allegro Pediatrics primary clinics within a 5 county region in western Washington (Snohomish, King, Pierce, Thurston, and Kitsap Counties) will be eligible to participate.
排除标准
- •Parents/Children: Parents who are not 18 years or older, require language interpretation for medical care, have an infant born <35 weeks gestation, are not vaccine hesitant or will not be taking their child to a participating clinic for health supervision visits will be excluded.
- •Providers: Clinics and providers outside the 5 county region in western Washington (Snohomish, King, Pierce, Thurston, and Kitsap) will be excluded.
研究组 & 干预措施
Placebo Arm
Parent participants will receive a placebo survey about their attitudes toward common child health topics before their child's health supervision visit.
干预措施: Placebo Survey (Behavioral)
Intervention Arm
Parent participants will also receive the intervention survey about their attitudes toward childhood vaccines before their child's health supervision visit.
干预措施: Intervention Survey (Behavioral)
结局指标
主要结局
Child's Mean Percent Days Under-immunized
时间窗: Child's immunization status at 8 months of age
Mean percent days under-immunized among children of parents who received (vs. did not receive) the intervention
次要结局
- Provider Perceptions of Barriers to the Vaccine Discussion(Change post-intervention from pre-intervention)
- Number of Parents With a Highly Rated Visit Experience(24-48 hours after the 6 month health supervision visit)
研究者
Douglas Opel
Principal Investigator
Seattle Children's Hospital